Evidence strategy for Medical Technologies and Diagnostics

Pharma Market Access Insights - from Mtech Access

Here, our experts explore evidence strategies for medical devices, diagnostics and digital health technologies.
Have you established the clinical and economic value of your medical device, diagnostic or digital technology? Do you have the evidence required to support your value proposition? Would a health technology assessment (HTA) route be appropriate for your product? What will payers, HTA agencies, and other key decision makers be looking for? And how should this information be presented?
In this episode, our experts in HTA, health economics, and commercialisation explore:
- How to identify and communicate the value of your product for patients and the wider healthcare system
- How to build a robust evidence package for successful launch and commercialisation
- Key requirements for the National Institute for Health and Care Excellence (NICE) Medical Technologies Evaluation Programme (MTEP) or Diagnostics Assessment Programme (DAP)
- Next steps to take your innovation to healthcare leaders across the NHS and beyond, with an impactful customer communication strategy
This episode was first broadcast as a live webinar in January 2023. Learn more and request a copy of the slides at: https://mtechaccess.co.uk/evidence-strategy-for-medical-technologies-and-diagnostics/
Discover how Mtech Access can support your commercialisation journey at: https://mtechaccess.co.uk/medical-device-market-access/

Subscribe to our newsletter to hear more news, insights and events from Mtech Access.

Kapitel

1. Introductions (00:00:00)

2. Market access for Medtech (00:04:50)

3. Identifying the value of your product (00:07:49)

4. Common challenges in value demonstration (00:08:47)

5. Building a robust evidence package (00:12:38)

6. Regulatory and HTA agency requirements (00:15:13)

7. NICE Medtech Early Technical Assessment (META) Tool (00:16:50)

8. Commercialisation of Medtech assets (00:30:26)

9. Activities to support product commercialisation (00:36:00)

10. Your questions answered (00:40:07)

11. Next steps (00:50:58)